ResMed Inc (NYSE:RMD) Builds on a Quality Foundation with Strong Profitability and Cash Conversion
17h agoen
From the article
Explore ResMed (RMD) as a quality investment with 68.2% ROIC, 92% cash conversion, low leverage, and 15.82% EBIT growth, scoring 8/10 in fundamentals.
Continue reading on ChartMillYou might also wanna read
Invesco S&P SmallCap 600 Pure Growth ETF (RZG) Declares $0.0856 Quarterly Distribution
Invesco S&P SmallCap 600 Pure Growth ETF (RZG) has declared a quarterly distribution of $0.0856 per share. The fund's 30-Day SEC Yield stand
This Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?
Bars·1d ago

MedTech and Healthcare Investments: Opportunities, Risks, and Examples
Invesdor·3mo ago
IT stocks with Strong Buy Quant Ratings for 60+ days: MU, CLS, CRDO highlighted
The article highlights information technology stocks that have maintained Seeking Alpha Strong Buy Quant Ratings for at least 60 days. It me
Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.
Bars·2d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.